faltered a bit for a while, our first permanent CEO, Bill McGivney, took us places we never imagined and helped us create a product in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) that has become synonymous with quality care around
Search Results
Steven M. Sorscher
Correspondence JNCCN is committed to providing a forum to enhance collaboration between academic medicine and the community physician. We welcome comments about the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), articles published in the
Margaret Tempero
Guidelines in Oncology (NCCN Guidelines) and related reviews. But we’re also going to publish more examples of putting molecular medicine into practice. Further, we will focus the publication on the highest quality original research in the areas of health
Julie M. Vose
Clinical Practice Guidelines in Oncology (NCCN Guidelines) for NHL in 2001-2002 were very basic and included broad recommendations regarding the diagnosis and therapy for 8 different histologic types of NHL. The guidelines were 48 pages in length and
William T. McGivney
works fully as described above! For a look at our solution, please visit NCCN.org and click on NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)! The ideas and viewpoints expressed in this editorial are those of the author and do
Margaret Tempero
Guidelines in Oncology (NCCN Guidelines), with insights into selected aspects of the guidelines. I knew that shouldn’t change. But I also knew from serving as chair of an NCCN Guidelines Panel, that there was often “more to the story.” Respecting that, we
David C. Hohn
and, later, major employers to educate them about the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) and the value of treatment and trials in our respective institutions. This strategy took us in several different directions. Dr
Robert W. Carlson
present the latest treatment advances, updates to the standard of care as recommended in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), and unique and challenging patient cases. This special issue of JNCCN—Journal of the National
Harold J. Burstein
Guidelines in Oncology (NCCN Guidelines) that are the core of the NCCN mission. The journal began as a quarterly publication in 2003, and moved to bi-monthly and now monthly publication. Each month, JNCCN is received by about 23,000 oncologists
Arjun Gupta
Guidelines in Oncology (NCCN Guidelines), articles published in the journal, or any other topic relating to cancer prevention, detection, treatment, supportive care, or survivorship. Please send correspondence to JNCCN.edmgr.com or to JNCCN